Amylyx Pharmaceuticals (AMLX) FCF/share US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| FCF/share, rub | -1.30 | -2.74 | 0.16 | -2.46 | -1.31 | -1.09 | |||
| Changes by years, y/y, % | +99% | +111% | -106% | -1 651% | -47% | +14.9% | |||
Amylyx Pharmaceuticals. FCF/share, rub
Amylyx Pharmaceuticals. FCF/share, changes, %
Amylyx Pharmaceuticals (AMLX) FCF/share US GAAP (quarter values) |
||||||||
| FY2025Q1 | FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| FCF/share, rub | -0.46 | -0.28 | -0.33 | -0.30 | -0.33 | -1.09 | ||
| Changes by years, y/y, % | +5 573% | -71% | -47% | -66% | -28% | |||
| Changes by quarters, q/q, % | -46% | -39% | +15% | -9% | +13% | |||